| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |